It has been another positive day for the Telstra Group Ltd (ASX: TLS) share price on Tuesday.

The telco giant’s shares returned from the Easter break in style by hitting a new multi-year high of $4.32.

When the Telstra share price hit that level, it meant it was up a solid 8% since the start of the year.

Can the Telstra share price keep rising?

Given that Telstra’s shares are now at a new multi-year high, investors may be wonder if there’s anything left in the tank.

The good news is that a number of brokers believe they can keep rising from current levels.

One of those is Morgans, which has the telco on its best ideas list again this month with an add rating and $4.70 price target. This implies potential upside of almost 9% from current levels.

In addition, the broker is expecting a 17 cents per share fully franked dividend both this year and next year. If we add this into the equation, investors can expect a total return of almost 13% over the next 12 months if Morgans is on the money with its recommendation.

What is the broker saying?

Morgans is bullish on the Telstra share price due to the company’s positive outlook. This is being underpinned by its restructure and potential asset divestments. It explained:

After a major turnaround, TLS has emerged in good shape with strong earnings momentum and a strong balance sheet. In late CY22 shareholders vote on Telstra’s legal restructure, which opens the door for value to be released. TLS currently trades on ~7x EV/EBITDA. However some of TLS’s high quality long life assets like InfraCo are worth substantially more, in our view. We don’t think this is in the price so see it as value generating for TLS shareholders. This, free option, combined with likely reputational damage to its closest peer, following a major cybersecurity incident, means TLS looks well placed for the year ahead.

The post Can the Telstra share price keep on rising? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Blue chip beat-down: 5 huge ASX 200 shares cementing new 52-week highs today
• How much do you need to invest to give up work and live only off dividend income?
• Are these ASX 200 dividend shares must-buys for passive income investors?
• Here are the 3 most heavily traded ASX 200 shares on Wednesday
• Big Wednesday: 12 ASX 200 stocks cracking new 52-week highs

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/M7Oi0XK

The S&P/ASX 200 Index (ASX: XJO) and ASX shares seem to have come back from the Easter break with a new spring in their collective step. At market close on Tuesday, the ASX 200 gained a very pleasing 1.25% at 7,309.1 points.

So is it a good time to buy ASX shares this week?

Well, I think the answer is ‘absolutely’. But not because the markets are going up today. In fact, I would have even more conviction if it was a red day today. So let’s discuss three reasons why I think it’s a good week to buy ASX shares.

Three reasons to buy ASX shares this week

King? Cash is still trash

You may be tempted to park any unused cash you have right now in a savings account or term deposit. To be fair, rising interest rates have made this option a lot more attractive over the past year. 12 months ago, it was difficult to find a term deposit yielding more than 1%. Today, you can nab one with an interest rate of up to around 5%.

But cash is still trash in my opinion at least compared to shares. Everyone should have a good store of liquid cash for that dreaded rainy day. But once you have enough money to fund an emergency account, history tells us that you get a bigger bang for your buck investing in shares.

Just a simple index fund like the Vanguard Australian Shares Index ETF (ASX: VAS) has averaged a return of 8% per annum over the past three years. Past returns are no guarantee of future success. But I’m willing to take my chances that history will repeat itself with this one.

Shares pay you income

Many investors like to buy assets that don’t produce cash flow. Collectables, fine wine, fine art, gold and even Bitcoin (CRYPTO: BTC) all have the potential to appreciate in value over time. But these kinds of assets don’t pay you passive income for the privilege of owning them like shares or property can do.

Most ASX 200 shares pay their shareholders dividends on a regular basis, many also come with additional franking credits, which can boost your income even further. Again, we’ll look to the Vanguard Australian Shares ETF to illustrate.

Over the past 12 months, investors have enjoyed four dividend distributions from this index fund. These total $4.94 per unit, which, on current pricing, gives this ETF a trailing distribution yield of 5.43%.

This represents real cash flow, which you can use to pay bills, or else, reinvest into even more income-producing shares.

The best time to buy ASX shares is usually yesterday

Everyone knows the share market can be a volatile place. But you can gain some real perspective by zooming out and looking at what the market does over the long term, rather than the short term:

It’s pretty obvious that shares go up far more often than they go down. And, as you can see above, the markets have never failed to exceed a previous all-time high in its long history. So mathematically, it makes sense to buy as many shares as you can today, without waiting for a better opportunity down the road.

The post 3 reasons to start buying ASX shares this week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• How I’m building more passive income to retire early
• Why is the Vanguard Australian Shares Index ETF (VAS) tumbling on Monday?
• Here are the ASX shares I was buying and selling in March
• Hoping to bag the next Vanguard Australian Shares Index ETF dividend? You’d better hurry
• No savings? Drip-feed $500 a month into ASX shares and aim to retire in comfort

Motley Fool contributor Sebastian Bowen has positions in Bitcoin and Vanguard Australian Shares Index ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Bitcoin. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/ViPKzN3

ASX lithium shares are having a top run on the market today.

Lithium shares in the green include:

• Core Lithium Ltd (ASX: CXO), up 2.3%
• Pilbara Minerals Ltd (ASX: PLS), up 2.22%
• Allkem Ltd (ASX: AKE), up 2.08%
• Lake Resources N.L. (ASX: LKE), up 2.22%

For perspective, the S&P/ASX 200 Index (ASX: XJO) is rising 1.27% today.

Let’s take a look at why ASX lithium shares are leaping higher today.

What’s going on?

ASX lithium shares appear to be following in the footsteps of their United States peers overnight.

The share price of New York Stock Exchange lithium giant Albemarle Corporation (NYSE: ALB) jumped 2.64% in the US overnight, while Livent Corp (NYSE: LTHM) shares rose 4.22%. Sociedad Quimica y Minera de Chile (NYSE: SQM) shares climbed 1.06%.

This was despite the lithium price sliding again. The Lithium Carbonate Index (battery grade) fell 3.04% to US$31,924.16 on the Shanghai Metals Market, while the Lithium Hydroxide Index (battery grade) fell 3.1% to US$43,538.22.

Lithium hydroxide has also fallen 3.01% on the London Metal Exchange to US$58,100.

Saxo Markets Australia market analyst Jessica Amir, quoted by The Australian yesterday, is positive on lithium long term but noted the sector is a “highly volatile space”. She said:

Investors are thinking the reporting season in August might be ugly compared to what it has been.

However, we are bullish long term on lithium.

Share price snapshot

The Core Lithium share price has fallen 31% in the last year, while Pilbara shares have gained 20%.

Allkem shares have slid 15%, while Lake Resources shares have descended nearly 77% in the last 12 months.

The post Why are ASX lithium shares leaping ahead today? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Arafura, Core Lithium, Mayne Pharma, and Newcrest shares are storming higher
• EverGreen Lithium share price rockets after IPO: everything you need to know
• 50% fall: Are ASX 200 lithium shares a bargain buy right now?
• These are the 10 most shorted ASX shares this week
• Buy Pilbara Minerals and these ASX growth shares in April: experts

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/P0YHgeW

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

Accent Group Ltd (ASX: AX1)

According to a note out of Goldman Sachs, its analysts have retained their buy rating and $3.10 price target on this footwear and athleisure retailer’s shares. Accent presented at Goldman Emerging Leaders conference and the broker was pleased with what it heard. It notes that cost pressures are starting to stabilise and Accent expects to offset this with one final price increase in July. In addition, it highlights that the company now has a higher return hurdle on new store openings to reflect a higher cost of capital. The Accent share price is trading at $2.48 today.

Alcidion Group Ltd (ASX: ALC)

A note out of Bell Potter reveals that its analysts have resume coverage on this commercial stage healthcare IT company’s shares with a speculative buy rating and 20 cents price target. The broker believes that Alcidion is well-placed to benefit from governments across the globe supporting and funding the upgrade of hospitals to digital records and patient management systems. The Alcidion share price is fetching 11.5 cents on Tuesday.

Eagers Automotive Ltd (ASX: APE)

Analysts at Morgans have retained their add rating and $15.85 price target on this auto seller’s shares. The broker highlights that electric vehicles (EV) sales have now hit 7.4% of the market. Morgans believes that Eagers is well-placed to benefit from this trend thanks to its direct leverage to EV penetration. The Eagers share price is trading at $13.75 this afternoon.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 5 things to watch on the ASX 200 on Tuesday
• Invest in this 6% yielding ASX 300 dividend stock for passive income
• Brokers name 3 ASX shares to buy now
• This ASX All Ords share has soared 70% in 6 months. Is it too late to buy?
• Don’t underestimate the earnings potential of this ASX 300 share: Goldman Sachs

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alcidion Group. The Motley Fool Australia has recommended Accent Group and Alcidion Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/7OA9jUp

Investing in S&P/ASX 200 Index (ASX: XJO) shares has never been easier.

At least as far as the actual buying and selling process goes.

It wasn’t too long ago that anyone wanting to buy ASX 200 shares needed to do so via a phone call or visit to their broker.

While that’s still an option – and some brokers can also offer investment advice for a fee – these days many investors choose to set up an online account and do their own buying and selling.

That’s certainly my preference.

With that said, here are three things I wish I knew before I started investing in ASX 200 shares.

Time in the markets, not timing the markets

Time in the markets, not timing the markets.

It’s a bit of a cliché for buy and hold investors. But clichés usually become clichés because they’re based on broad truths.

As an economist with a good grasp of macroeconomic trends, it’s all too tempting to try and buy into ASX 200 shares when I believe they’re at a low. And then perhaps sell them when I believe the high is in.

While I might get this close to right every now and again, successfully timing the market with any kind of consistency is essentially impossible.

If it wasn’t, there’d be a whole lot more billionaires sitting on the sidelines.

Rather than trying to guess what an ASX 200 share is going to be trading for next month, I wish I’d known to take the long view and invest in quality well-managed companies, operating in growing markets, that are able to keep the competition at arm’s length.

Five years down the road, history shows there’s a good chance these companies will be worth significantly more than they are today.

And trying to time the ideal entry often leads to missing out entirely.

A diversified ASX 200 share portfolio

Just as with timing the market, it can be tempting to try to pick a few winners out of the pack.

But investing all of your money into just a few ASX 200 shares comes with a lot more risk than spreading out your investments across a wider basket of stocks.

And those stocks should ideally operate across a range of sectors. That way if a particular sector comes under pressure – think the banking sector last month – not all of your holdings will lose value.

One thing that would have been handy to know back in the day is the potential appeal of exchange-traded funds (ETFs).

There are a number of ETFs to consider that closely track the performance of a range of ASX 200 shares. Some are sector-specific. Others are intended to track the broader benchmark. All of these offer investors instant diversification with a single share purchase.

Read, read, read…

Which brings us to the third thing I wish I knew before I started investing in ASX 200 shares.

Read, read, and read some more.

If you’re like me, you probably have worked hard for the money you plan to invest.

So make sure you do your research on the companies you plan to buy into before placing your order.

Half-year and annual results should be considered a must-read. You can find these on the company websites, the ASX website, and The Motley Fool website, among other sources.

Now, these reports may look daunting at first glance. But once you get how they’re put together, you can usually get the information on the ASX 200 shares that you’re after fairly quickly.

Make sure to check out how the company has been performing this year compared to prior years. And investigate the growth outlook, both via the company’s own guidance and any professional broker coverage you have access to.

There are also plenty of handy investment newsletters you can subscribe to. Some are free, others will charge you a subscription fee.

How ever you decide to come about your research, don’t skimp on the reading.

The post 3 things I wish I knew before I started investing in ASX 200 shares appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 2 ASX 200 shares that could be top buys for growth
• 5 things to watch on the ASX 200 on Tuesday
• Will the ASX 200 hit 7,500 again in 2023?
• Here are the top 10 ASX 200 shares today
• Here are the 3 most heavily traded ASX 200 shares on Thursday

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Mz1rNG5

The Appen Ltd (ASX: APX) share price has taken a beating over the last 12 months, tumbling nearly 60% in that time.

Right now, stock in the tech outfit is trading for $2.635 apiece. This time last year, it was swapping hands for $6.55 per share.

For comparison, the All Ordinaries Index (ASX: XAO) has dumped 3% in that time while the S&P/ASX All Technology Index (ASX: XTX) has dropped 7%.

So, could now be the time to jump on board Appen shares and make the most of a potential recovery? Let’s take a look.

What went wrong for the Appen share price?

The last 12 months have been a rollercoaster for those invested in the data and services provider’s stock. Appen provides speech and language data to companies involved with artificial intelligence and machine learning.

The former market darling listed in 2015 after offering shares for 50 cents apiece in its initial public offering (IPO). It later rocketed to a record high of $42.53 in 2020.

However, its time in the sun was brief. The stock had hit a low of $2.22 by late 2022.

In the meantime, it was presented with a $9.50 per share, $1.2 billion takeover bid. Though, that was withdrawn within 24 hours of its announcement.

Between the offer being tabled and retracted, Appen revealed its earnings before interest, tax, depreciation, and amortisation (EBITDA) for the first half of financial year 2022 would likely be lower than the prior period.

And its earnings continued to fall in the second half. Its full year underlying EBITDA, revealed in February, came to just US$11 million – an 86% year-on-year tumble.

Simultaneously, soaring inflation and resulting rate hikes saw the market bidding down many ASX tech shares.

But with AI taking the public by storm in 2023 – take the rise of ChatGPT for example – could the future be brighter for the Appen share price?

Is now the time to snap up the ASX tech stock?

Datt Capital chief investment officer Emanuel Datt appears hopeful. The expert said, courtesy of reporting by my Fool colleague Tony:

Appen… has experienced significant downward pressure on the share price at the same time as AI has catapulted into mainstream consciousness via the launch of OpenAI’s ChatGPT … We view this environment becoming more crowded and highly competitive.

Meanwhile, recent insider buying suggests those in the know are bullish on the stock.

Still, broker Bell Potter remains unconvinced. It tipped the Appen share price to fall 15% to $2.25.

It downgraded the stock following the release of the company’s full year earnings, in which it dropped its financial year 2026 targets pending a full strategy review to be announced next month.

Appen also noted it’s seen “a soft start” to the new year and expects its first half EBITDA to be “materially lower” than that of the prior period.

The post Down 60% in a year, are Appen shares a bargain buy? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 3 ‘compelling’ ASX tech shares cheap enough to buy now
• Why Appen, Harvey Norman, Healthco, and Lake shares are dropping today
• Why Appen, Regis Resources, Syrah, and Zip shares are charging higher today
• This beaten-up ASX 300 tech share is down 60% in a year, and directors are buying it up
• Guess which beaten-up ASX 300 tech share is up 16% this month

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Appen. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/yvLgNm6

The S&P/ASX 200 Index (ASX: XJO) stock Centuria Industrial REIT (ASX: CIP) could be a very pleasing source of passive income. It could provide $750 of monthly income with a large enough investment.

There is plenty of talk about what damage interest rates are doing to property values. Higher interest rates also mean that the interest expense for real estate investment trusts (REITs) is increasing.

But, over the past year, the Centurial Industrial REIT share price has dropped by more than 20%. This gives investors the opportunity to invest in the industrial property owner at a much cheaper price.

Industrial properties are still seeing high demand, which has led to a very high occupancy rate and faster-growing rent. The increased level of e-commerce compared to pre-COVID is helping boost the demand for logistics and distribution warehouses.

$750 of monthly income

The ASX 200 stock pays out a lot of the rental profit that it makes each year. This helps the business maintain a relatively high distribution yield.

According to Commsec, the business is projected to pay an annual distribution of 16 cents per unit in FY23. This translates into a forward distribution yield of 5.4%.

If we think of the goal of $750 of passive income per month for an annual goal of $9,000, then investors would need to own 56,250 units of the REIT.

That would be a large investment, but it reflects what’s needed.

But, according to Commsec, the business is expected to increase its distribution to 16.5 cents per share in FY25.

If investors just focus on this projected amount, to receive $9,000 per year we’d need 54,545 units.

Is the ASX 200 stock a good buy for passive income?

The fund manager of the REIT, Jesse Curtis, recently said:

Despite continued macroeconomic uncertainty, robust tenant demand coupled with limited supply of industrial supply of industrial space continues to drive market rental rises nationally, accelerating re-leasing spreads…

The portfolio is well-positioned with high occupancy and strong, reliable rental streams. Though transaction volumes have moderated during 2022, industrial asset values are continuing to hold with uplift in market rental growth counteracting capitalisation rate expansion.

The REIT share price is currently trading at a 27% discount to its net tangible assets (NTA) per unit of $4.08 at 31 December 2022. While the NTA may drop, I think a current discount of 27% gives a healthy margin of safety.

After the recent share price fall, I think the ASX 200 stock can be a pleasing option for passive income.

The post For $750 in monthly passive income, buy 56,250 shares of this ASX 200 stock appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 3 big dividend-paying ASX shares for 2023
• 5 things to watch on the ASX 200 on Thursday
• 8 ASX All Ords shares trading ex-dividend this week
• Get a passive income boost with these ASX dividend shares: experts

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/WVm314I

The S&P/ASX 200 Index (ASX: XJO) is back from the Easter break with a bang. In afternoon trade, the benchmark index is up 1.3% to 7,312.2 points.

Four ASX shares that are climbing more than most today are listed below. Here’s why they are storming higher:

Arafura Rare Earths Ltd (ASX: ARU)

The Arafura share price is up 6% to 50.8 cents. Investors have been buying this rare earths developer’s shares after it announced a binding offtake agreement with Siemens Gamesa Renewable Energy. The wind industry leader has signed an agreement for up to 400 tonnes per annum (tpa) of neodymium and praseodymium (NdPr) metal from the Nolans project.

Core Lithium Ltd (ASX: CXO)

The Core Lithium share price is up 3.5% to 90 cents. This is despite there being no news out of the lithium miner. However, it is worth noting that a number of ASX lithium shares are charging higher on Tuesday. This follows a decent night of trade for lithium stocks on Wall Street.

Mayne Pharma Group Ltd (ASX: MYX)

The Mayne Pharma share price is up 4.5% to $4.16. This follows news that the pharmaceutical company has completed the sale of its US generics portfolio. According to the release, Mayne Pharma has received US$90 million (~A$134 million) for the portfolio of commercial, pipeline, and approved non-marketed products. The agreement also includes a 10-year supply agreement for certain products and provides for up to US$15 million (~A$22 million) in contingent milestone payments.

Newcrest Mining Ltd (ASX: NCM)

The Newcrest share price is up 5% to $29.74. This morning, this gold miner revealed that it has received an improved takeover offer from North American peer Newmont Mining. Newmont has made an offer of $32.87 per share, which is up from its last offer of $27.40. This has been enough to get the Newcrest board to grant due diligence access.

The post Why Arafura, Core Lithium, Mayne Pharma, and Newcrest shares are storming higher appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• EverGreen Lithium share price rockets after IPO: everything you need to know
• Here’s why the Arafura share price is racing 11% higher
• Newcrest share price jumps on new takeover offer
• 50% fall: Are ASX 200 lithium shares a bargain buy right now?
• These are the 10 most shorted ASX shares this week

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/JB4Gsnl

If you’re looking for dividends shares to buy this month, then you may want to check out the two listed below.

Here’s what you need to know about these high yield ASX dividend shares:

Healthco Healthcare and Wellness REIT (ASX: HCW)

The first ASX dividend share for passive income investors to look at is the Healthco Healthcare and Wellness REIT.

As you might expect from its name, it is a health and wellness focused real estate investment trust. The company invests in properties including hospitals, aged care, childcare, government, life sciences and research, and primary care and wellness centres.

Morgans is a fan of the company and is forecasting big dividend yields from its shares.

For example, the broker is expecting dividends per share of 7.5 cents in FY 2023 and 7.8 cents FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.35, this will mean yields of 5.5% and 5.8% for investors.

Morgans also sees plenty of upside for its shares. It currently has an add rating and $2.06 price target on them.

Mineral Resources Ltd (ASX: MIN)

Another high yield ASX dividend share that has been named as a buy is Mineral Resources.

It is a mining and mining services company with operations across energy, iron ore, and lithium.

Bell Potter is a big fan of Mineral Resources. This is due to its belief that the company is well-placed for strong earnings and dividend growth in the coming years thanks to its business transformation. It highlights that this will support “growing production volumes and improving margins.”

In respect to dividends, the broker is forecasting fully franked dividends of 373.4 cents per share in FY 2023 and then 940.9 cents per share in FY 2024. Based on the current Mineral Resources share price of $78.58, this will mean 4.8% and 12% dividend yields, respectively.

Bell Potter has a buy rating and $111.00 price target on its shares.

The post Passive income investors can get big yields from these top ASX dividend shares: experts appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• ASX 200 lithium stocks sink again following Albemarle downgrade
• Which is the best ASX 200 iron ore stock now: BHP, Fortescue, or Mineral Resources?
• Top ASX growth shares to buy in April 2023
• Why are ASX 200 lithium shares having such a miserable week?
• Brokers say these ASX dividend shares are buys

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Elders. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/zUcN4BP

The CSL Ltd (ASX: CSL) share price lagged the S&P/ASX 200 Index in the first quarter of 2023.

Shares in the ASX 200 biotechnology company closed out 2022 trading for $287.76. When the closing bell rang on 31 March, those same shares were trading for $288.30, up 0.2%.

While that put the CSL share price in positive territory for Q1 2023, it underperformed the benchmark index, which gained 2% over the three months.

Here’s how the quarter unfolded.

What happened over the first quarter?

If you have a look at the price chart at the end of this article, you’ll see that the CSL share price enjoyed a strong run in the early weeks of 2023.

On 3 February, shares closed at $313.81, notching fresh one-year highs.

Alongside the broader rising market at the time, the biotech giant looks to have benefited from some positive broker coverage.

Morgans was among those bullish brokers, adding CSL to its best ideas list for February. Morgans has a price target for CSL shares of $312.20.

Morgan Stanley also was positive on the company’s stock, reaffirming its overweight rating with a $354 price target.

From 3 February through to 31 March, the CSL share price went the other direction though, falling 8.1% over that period.

One headwind could be that investors were pricing in news released on 3 February that GSK plc (NYSE: GSK), a rival biotech stock, had received approval from the United States Food and Drug Administration for a competing drug to treat anaemia caused by chronic kidney disease.

CSL also reported its half-year results on 14 February.

The biotech company reported a 19% year-on-year increase in total revenue for the six months to US$7.2 billion.

But profits were hit by currency headwinds and increased acquisition costs. This saw net profit after tax (NPAT) decline 8% year on year to US$1.6 billion.

The CSL share price also slipped 2.2% on 9 March. That’s the day it traded without rights to the interim dividend of $1.62, unfranked.

CSL share price snapshot

As you can see in the chart below, the CSL has enjoyed a strong start to April, with shares up 5% so far this month.

The post <strong>Why did the CSL share price lag the ASX 200 in the first quarter of 2023?</strong> appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Build your portfolio around these ASX 200 blue chip shares: brokers
• Top defensive ASX shares to buy in April 2023
• Top brokers name 3 ASX shares to buy next week
• My top 5 ASX shares to buy and hold forever in anticipation of the bull market
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended GSK. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/oKvU2TW